Annual Current Assets
$132.03 M
-$19.11 M-12.65%
31 December 2023
Summary:
Arbutus Biopharma annual total current assets is currently $132.03 million, with the most recent change of -$19.11 million (-12.65%) on 31 December 2023. During the last 3 years, it has fallen by -$28.63 million (-17.82%). ABUS annual current assets is now -28.20% below its all-time high of $183.88 million, reached on 31 December 2015.ABUS Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$132.78 M
-$15.44 M-10.42%
30 September 2024
Summary:
Arbutus Biopharma quarterly total current assets is currently $132.78 million, with the most recent change of -$15.44 million (-10.42%) on 30 September 2024. Over the past year, it has increased by +$750.00 thousand (+0.57%). ABUS quarterly current assets is now -44.62% below its all-time high of $239.77 million, reached on 31 March 2015.ABUS Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABUS Current Assets Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | +0.6% |
3 y3 years | -17.8% | -17.4% |
5 y5 years | +40.7% | +41.5% |
ABUS Current Assets High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -17.8% | at low | -23.1% | +0.6% |
5 y | 5 years | -17.8% | +40.7% | -23.1% | +59.1% |
alltime | all time | -28.2% | +2285.3% | -44.6% | +1418.9% |
Arbutus Biopharma Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $132.78 M(-10.4%) |
June 2024 | - | $148.22 M(+9.1%) |
Mar 2024 | - | $135.87 M(+2.9%) |
Dec 2023 | $12.37 M(-72.1%) | $132.03 M(-6.8%) |
Sept 2023 | - | $141.61 M(-10.8%) |
June 2023 | - | $158.80 M(+3.9%) |
Mar 2023 | - | $152.85 M(+1.1%) |
Dec 2022 | $44.28 M(+1.0%) | $151.14 M(+7.1%) |
Sept 2022 | - | $141.14 M(-10.6%) |
June 2022 | - | $157.79 M(-8.6%) |
Mar 2022 | - | $172.70 M(+7.5%) |
Dec 2021 | $43.82 M(+367.4%) | $160.66 M(+27.0%) |
Sept 2021 | - | $126.54 M(+51.6%) |
June 2021 | - | $83.47 M(-39.2%) |
Mar 2021 | - | $137.34 M(+7.5%) |
Dec 2020 | $9.38 M(-19.9%) | $127.70 M(+5.3%) |
Sept 2020 | - | $121.24 M(+41.7%) |
June 2020 | - | $85.54 M(-3.2%) |
Mar 2020 | - | $88.33 M(-5.9%) |
Dec 2019 | $11.71 M(-88.1%) | $93.83 M(-0.5%) |
Sept 2019 | - | $94.34 M(-5.3%) |
June 2019 | - | $99.58 M(-11.5%) |
Mar 2019 | - | $112.49 M(-13.0%) |
Dec 2018 | $98.68 M(-8.5%) | $129.23 M(-10.3%) |
Sept 2018 | - | $144.03 M(-8.7%) |
June 2018 | - | $157.77 M(-9.9%) |
Mar 2018 | - | $175.19 M(+35.4%) |
Dec 2017 | $107.80 M(-24.8%) | $129.37 M(+42.5%) |
Sept 2017 | - | $90.81 M(-14.3%) |
June 2017 | - | $105.92 M(-11.9%) |
Mar 2017 | - | $120.27 M(-9.3%) |
Dec 2016 | $143.35 M(-72.9%) | $132.56 M(-12.7%) |
Sept 2016 | - | $151.81 M(-9.7%) |
June 2016 | - | $168.09 M(-3.8%) |
Mar 2016 | - | $174.76 M(-5.0%) |
Dec 2015 | $528.41 M(>+9900.0%) | $183.88 M(-8.1%) |
Sept 2015 | - | $200.03 M(-7.3%) |
June 2015 | - | $215.70 M(-10.0%) |
Mar 2015 | - | $239.77 M(+106.0%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2014 | $1.76 M(+28.2%) | $116.42 M(+4.2%) |
Sept 2014 | - | $111.74 M(-5.4%) |
June 2014 | - | $118.16 M(-13.7%) |
Mar 2014 | - | $137.00 M(+94.8%) |
Dec 2013 | $1.37 M(+1.6%) | $70.34 M(+67.4%) |
Sept 2013 | - | $42.01 M(-5.7%) |
June 2013 | - | $44.54 M(-9.4%) |
Mar 2013 | - | $49.14 M(-4.1%) |
Dec 2012 | $1.35 M(-37.2%) | $51.24 M(+486.2%) |
Sept 2012 | - | $8.74 M(-11.9%) |
June 2012 | - | $9.92 M(-22.1%) |
Mar 2012 | - | $12.73 M(+10.2%) |
Dec 2011 | $2.15 M(-30.9%) | $11.55 M(-7.7%) |
Sept 2011 | - | $12.51 M(-23.1%) |
June 2011 | - | $16.27 M(+13.1%) |
Mar 2011 | - | $14.39 M(-19.6%) |
Dec 2010 | $3.11 M(-1.9%) | $17.91 M(-3.3%) |
Sept 2010 | - | $18.52 M(-0.5%) |
June 2010 | - | $18.62 M(-3.8%) |
Mar 2010 | - | $19.36 M(-21.9%) |
Dec 2009 | $3.17 M(-78.9%) | $24.79 M(-7.2%) |
Sept 2009 | - | $26.72 M(+2.7%) |
June 2009 | - | $26.01 M(+4.0%) |
Mar 2009 | - | $25.00 M(-8.5%) |
Dec 2008 | $15.01 M(+874.5%) | $27.33 M(-21.6%) |
Sept 2008 | - | $34.86 M(-13.1%) |
June 2008 | - | $40.13 M(+96.7%) |
Mar 2008 | - | $20.40 M(-12.4%) |
Dec 2007 | $1.54 M(+208.3%) | $23.29 M(-4.9%) |
Sept 2007 | - | $24.48 M(+3.1%) |
June 2007 | - | $23.74 M |
Dec 2006 | $499.70 K(-93.4%) | - |
Dec 2005 | $7.57 M(-38.7%) | - |
Dec 2004 | $12.36 M(+16.3%) | - |
Dec 2003 | $10.63 M(-40.3%) | - |
Dec 2001 | $17.83 M(+144.4%) | - |
Dec 2000 | $7.29 M(-15.0%) | - |
Dec 1999 | $8.58 M(-4.8%) | - |
Dec 1998 | $9.02 M | - |
FAQ
- What is Arbutus Biopharma annual total current assets?
- What is the all time high annual current assets for Arbutus Biopharma?
- What is Arbutus Biopharma quarterly total current assets?
- What is the all time high quarterly current assets for Arbutus Biopharma?
- What is Arbutus Biopharma quarterly current assets year-on-year change?
What is Arbutus Biopharma annual total current assets?
The current annual current assets of ABUS is $132.03 M
What is the all time high annual current assets for Arbutus Biopharma?
Arbutus Biopharma all-time high annual total current assets is $183.88 M
What is Arbutus Biopharma quarterly total current assets?
The current quarterly current assets of ABUS is $132.78 M
What is the all time high quarterly current assets for Arbutus Biopharma?
Arbutus Biopharma all-time high quarterly total current assets is $239.77 M
What is Arbutus Biopharma quarterly current assets year-on-year change?
Over the past year, ABUS quarterly total current assets has changed by +$750.00 K (+0.57%)